Most cited papers in Chemotherapy-related skin toxicity
What are the most cited papers in Chemotherapy-related skin toxicity?
The most cited paper in Chemotherapy-related skin toxicity is "Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy" (Norikazu Masuda et al., 2017), with 1,947 citations. Next come "Paclitaxel (Taxol)" (1,879) and "The side effects of platinum-based chemotherapy drugs: a review for chemists" (1,735).
Showing 50 of 100 papers. Every paper with more than 369 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy Norikazu Masuda et al. · New England Journal of Medicine | 31 May 2017 | 1,947 |
| 2 | Paclitaxel (Taxol) Eric Keith Rowinsky, Ross C. Donehower · New England Journal of Medicine | 13 Apr 1995 | 1,879 |
| 3 | The side effects of platinum-based chemotherapy drugs: a review for chemists Rabbab Oun, Yvonne E. Moussa, Nial Wheate · Dalton Transactions | 2018 | 1,735 |
| 4 | Cremophor EL Hans A. J. Gelderblom, Jaap Verweij, Kees Nooter et al. · European Journal of Cancer | Sep 2001 | 1,658 |
| 5 | Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis Marta Seretny, Gillian L. Currie, Emily S. Sena et al. · Pain | 23 Sep 2014 | 1,585 |
| 6 | Hypersensitivity reactions from taxol. R B Weiss, Ross C. Donehower, Peter H. Wiernik et al. · Journal of Clinical Oncology | Jul 1990 | 1,188 |
| 7 | Paclitaxel and its formulations Anil Kumar Singla, Alka B. Garg, Deepika Aggarwal · International Journal of Pharmaceutics | Mar 2002 | 1,099 |
| 8 | 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours Matti Aapro, Julia Bohlius, David Cameron et al. · European Journal of Cancer | 21 Nov 2010 | 1,094 |
| 9 | Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study Eric Van Cutsem et al. · Journal of Clinical Oncology | Nov 2001 | 1,042 |
| 10 | On the receiving end—patient perception of the side-effects of cancer chemotherapy Alan Stuart Coates, Suzanne F. Abraham, S.B. Kaye et al. · European Journal of Cancer and Clinical Oncology | Feb 1983 | 1,004 |
| 11 | Clinical Pharmacology of 5-Fluorouracil Robert B. Diasio, Barry Harris · Clinical Pharmacokinetics | Apr 1989 | 976 |
| 12 | Chemotherapy-induced peripheral neuropathy Stefan Quasthoff, Hans Peter Hartung · Journal of Neurology | 2002 | 973 |
| 13 | Treatment of a first patient with FLASH-radiotherapy Jean Bourhis, Wendy Jeanneret Sozzi, Patrik Gonçalves Jorge et al. · Radiotherapy and Oncology | 11 Jul 2019 | 959 |
| 14 | Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity G. Gordon Steel, Michael Peckham · International Journal of Radiation Oncology*Biology*Physics | 1979 | 913 |
| 15 | CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas Azael Freites‐Martínez, N. Santana, Salvador Arias‐Santiago et al. · Actas Dermo-Sifiliográficas | 3 Sep 2020 | 898 |
| 16 | Chemotherapy‐induced neutropenia Jeffrey Crawford, David C. Dale, Gary H. Lyman · Cancer | 5 Jan 2004 | 888 |
| 17 | Erythropoietin SB Krantz · Blood | Feb 1991 | 878 |
| 18 | Cardiovascular Complications of Cancer Therapy Edward T.H. Yeh, Ann T. Tong, Daniel John Lenihan et al. · Circulation | 28 Jun 2004 | 852 |
| 19 | Hidradenitis Suppurativa Gregor B. E. Jemec · New England Journal of Medicine | 11 Jan 2012 | 816 |
| 20 | The Anthracycline Antineoplastic Drugs Robert C. Young, Robert F. Ozols, Charles Edwin Myers · New England Journal of Medicine | 16 Jul 1981 | 800 |
| 21 | A clinical and pathological staging system for soft tissue sarcomas William O. Russell, Jonathan D. Cohen, Franz M. Enzinger et al. · Cancer | Oct 1977 | 767 |
| 22 | Chemotherapy‐induced peripheral neurotoxicity: A critical analysis Susanna B. Park, David B Goldstein, Arun V. Krishnan et al. · CA A Cancer Journal for Clinicians | Nov 2013 | 758 |
| 23 | Hidradenitis suppurativa: A comprehensive review Ali Alikhan, Peter Lynch, Daniel Brian Eisen · Journal of the American Academy of Dermatology | 17 Mar 2009 | 707 |
| 24 | Clinical toxicities encountered with paclitaxel (Taxol). E K Rowinsky, E A Eisenhauer, V Chaudhry et al. · PubMed | Aug 1993 | 697 |
| 25 | Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy Hana Starobova, Irina Vetter · Frontiers in Molecular Neuroscience | 31 May 2017 | 671 |
| 26 | Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects Nuno C. Santos, J. Figueira-Coelho, João Martins‐Silva et al. · Biochemical Pharmacology | 25 Mar 2003 | 655 |
| 27 | Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity Michael S. Ewer, Scott Michael Lippman · Journal of Clinical Oncology | 28 Apr 2005 | 651 |
| 28 | Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006 Sharon R. Hymes, Eric A. Strom, Caroline E. Fife · Journal of the American Academy of Dermatology | 29 Dec 2005 | 650 |
| 29 | A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention Andrew C. Chen, Andrew James Martin, Bonita Choy et al. · New England Journal of Medicine | 22 Oct 2015 | 644 |
| 30 | Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Nuhad K. Ibrahim, Neil P. Desai, Sewa S. Legha et al. · PubMed | May 2002 | 630 |
| 31 | Chemotherapy‐induced neuropathy Anthony J. Windebank, Wolfgang Grisold · Journal of the Peripheral Nervous System | Mar 2008 | 614 |
| 32 | Causes of death in cancer patients Jiro Inagaki, Victorio Rodriguez, Gerald P. Bodey · Cancer | Feb 1974 | 605 |
| 33 | Fluoroscopically Guided Interventional Procedures: A Review of Radiation Effects on Patients’ Skin and Hair Stephen Balter, J. W. Hopewell, Donald L. Miller et al. · Radiology | 21 Jan 2010 | 601 |
| 34 | Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases Mariana Castells, Nichole M. Tennant, David E. E. Sloane et al. · Journal of Allergy and Clinical Immunology | 28 May 2008 | 599 |
| 35 | The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20 Tjeerd J. Postma, Neil K. Aaronson, Jan J. Heimans et al. · European Journal of Cancer | 15 Apr 2005 | 595 |
| 36 | Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation Sylvie Euvrard, Emmanuel Morélon, Lionel P. E. Rostaing et al. · New England Journal of Medicine | 25 Jul 2012 | 592 |
| 37 | Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site Heather C. DeGrendele, Pila Estess, Mark H. Siegelman · Science | 24 Oct 1997 | 572 |
| 38 | Arm Edema in Breast Cancer Patients Virginia Erickson, Mark Pearson, PA Ganz et al. · JNCI Journal of the National Cancer Institute | 17 Jan 2001 | 566 |
| 39 | Cutaneous side-effects of kinase inhibitors and blocking antibodies Caroline Robert, Jean‐Charles Soria, Alan Spatz et al. · The Lancet Oncology | 30 Jun 2005 | 553 |
| 40 | Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. Maury Rosenstein, Stephen E. Ettinghausen, Steven A. Rosenberg · The Journal of Immunology | Sep 1986 | 533 |
| 41 | Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Keun Seok Lee, Hyun Cheol Chung, Seock Ah Im et al. · Breast Cancer Research and Treatment | 2 May 2007 | 525 |
| 42 | Totally implanted venous and arterial access system to replace external catheters in cancer treatment. John E. Niederhuber, William D. Ensminger, John W. Gyves et al. · PubMed | Oct 1982 | 498 |
| 43 | Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. Luck Jv · PubMed | Jun 1959 | 494 |
| 44 | Management and Preparedness for Infusion and Hypersensitivity Reactions Heinz‐Josef Lenz · The Oncologist | May 2007 | 492 |
| 45 | Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemia CHARLOTTE T.C. TAN, Hideko Tasaka, Kou-Ping Yu et al. · Cancer | 1967 | 492 |
| 46 | Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Olli Arola, Antti Saraste, Kari J. Pulkki et al. · PubMed | Apr 2000 | 491 |
| 47 | Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment E. Donnall Thomas, Henry Gómez, Rubi K. Li et al. · Journal of Clinical Oncology | 29 Oct 2007 | 484 |
| 48 | Immune checkpoint inhibitor–related dermatologic adverse events Amaris N. Geisler, Gregory S. Phillips, Dulce M. Barrios et al. · Journal of the American Academy of Dermatology | 23 May 2020 | 483 |
| 49 | Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer Harry D. Bear, Gong Tang, Priya Rastogi et al. · New England Journal of Medicine | 26 Jan 2012 | 473 |
| 50 | Incidence of chemotherapy‐induced nausea and emesis after modern antiemetics Steven M. Grunberg, Robert R. Deuson, Panagiotis Mavros et al. · Cancer | 12 Apr 2004 | 473 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.